MétaCan
Menu
Back to cohort
Record W2588410595 · doi:10.18632/oncotarget.15237

Metabolic heterogeneity signature of primary treatment-naïve prostate cancer

2017· article· en· W2588410595 on OpenAlexafffundabout
Dong Lin, Susan Ettinger, Sifeng Qu, Hui Xue, Noushin Nabavi, Stephen Yiu Chuen Choi, Robert H. Bell, Fan Mo, Anne Haegert, Peter W. Gout, Neil Fleshner, Martin Gleave, Michaël Pollak, Colin C. Collins, Yuzhuo Wang

Bibliographic record

VenueOncotarget · 2017
Typearticle
Languageen
FieldMedicine
TopicProstate Cancer Treatment and Research
Canadian institutionsMcGill UniversityVancouver General HospitalUniversity of TorontoUniversity Health NetworkUniversity of British ColumbiaPrincess Margaret Cancer CentreBC Cancer Agency
FundersCanadian Institutes of Health ResearchBC Cancer FoundationProstate Cancer Canada
KeywordsProstate cancerMedicineCancerOncologyInternal medicineGerontology

Abstract

fetched live from OpenAlex

// Dong Lin 1,2,* , Susan L. Ettinger 1,* , Sifeng Qu 1,2 , Hui Xue 2 , Noushin Nabavi 1,2 , Stephen Yiu Chuen Choi 1,2 , Robert H. Bell 1 , Fan Mo 1 , Anne M. Haegert 1 , Peter W. Gout 2 , Neil Fleshner 3 , Martin E. Gleave 1 , Michael Pollak 4 , Colin C. Collins 1 and Yuzhuo Wang 1,2 1 The Vancouver Prostate Centre, Vancouver General Hospital and Department of Urologic Sciences, The University of British Columbia, Vancouver, British Columbia, Canada 2 Department of Experimental Therapeutics, BC Cancer Research Centre, Vancouver, British Columbia, Canada 3 Division of Urology, University of Toronto, Department of Urology, University Health Network, Princess Margaret Hospital, Toronto, Ontario, Canada 4 Lady Davis Research Institute and McGill University, Montreal, Quebec, Canada * Co-first Authors Correspondence to: Yuzhuo Wang, email: // Colin C. Collins, email: // Michael Pollak, email: // Keywords : prostate cancer; tumour heterogeneity; metabolic heterogeneity; patient-derived xenografts Received : January 20, 2017 Accepted : January 25, 2017 Published : February 09, 2017 Abstract To avoid over- or under-treatment of primary prostate tumours, there is a critical need for molecular signatures to discriminate indolent from aggressive, lethal disease. Reprogrammed energy metabolism is an important hallmark of cancer, and abnormal metabolic characteristics of cancers have been implicated as potential diagnostic/prognostic signatures. While genomic and transcriptomic heterogeneity of prostate cancer is well documented and associated with tumour progression, less is known about metabolic heterogeneity of the disease. Using a panel of high fidelity patient-derived xenograft (PDX) models derived from hormone-naïve prostate cancer, we demonstrated heterogeneity of expression of genes involved in cellular energetics and macromolecular biosynthesis. Such heterogeneity was also observed in clinical, treatment-naïve prostate cancers by analyzing the transcriptome sequencing data. Importantly, a metabolic gene signature of increased one-carbon metabolism or decreased proline degradation was identified to be associated with significantly decreased biochemical disease-free patient survival. These results suggest that metabolic heterogeneity of hormone-naïve prostate cancer is of biological and clinical importance and motivate further studies to determine the heterogeneity in metabolic flux in the disease that may lead to identification of new signatures for tumour/patient stratification and the development of new strategies and targets for therapy of prostate cancer.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.194
Threshold uncertainty score0.549

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0010.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.041
GPT teacher head0.362
Teacher spread0.321 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations26
Published2017
Admission routes3
Has abstractyes

Explore more

Same venueOncotargetSame topicProstate Cancer Treatment and ResearchFrench-language works237,207